drugset / Trial / NCT03105843

Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Mannitol

NCT03105843

Phase 4 Recruiting 30 enrolled Dr. Diane Lougheed
RandomizedCrossoverOpen-labelBasic science

Summary

The objectives of this study are to determine the sensory-mechanical responses to Eucapneic Voluntary Hyperventilation (EVH) and Mannitol in individuals with cough variant asthma (CVA) and methacholine-induced cough with normal airway sensitivity (COUGH) and compare these responses to a control group of healthy individuals without asthma or chronic cough. We hypothesize: 1. EVH and Mannitol cause dyspnea, cough, small airway obstruction with resultant dynamic hyperinflation, gas trapping and autoPEEP in individuals with CVA and COUGH, but not healthy controls. 2. The sensory-mechanical responses to both hyperosmolar challenges (EVH and Mannitol) are comparable within groups (CVA, COUGH and healthy controls).

Timeline

Start
2022-03-01
Primary completion
2026-06-01
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Mannitol Diagnostic / imaging agent Inhaled
Background Methacholine Diagnostic / imaging agent 0.0625 mg/ml Inhaled
Background Methacholine Diagnostic / imaging agent 16 mg/ml Inhaled

Indications